We are live on ! Find out more
Rafferty Asset Management

Rafferty Asset Management Portfolio holdings

AUM $24.6B
1-Year Est. Return 47.06%
This Fund
S&P 500
This Quarter Est. Return
+17.95%
1 Year Est. Return
+47.06%
3 Year Est. Return
+108.18%
5 Year Est. Return
+135.84%
10 Year Est. Return
+427.13%
AUM
$10.2B
AUM Growth
+$1.96B
Cap. Flow
+$643M
Cap. Flow %
6.28%
Top 10 Hldgs %
43.19%
Holding
1,081
New
132
Increased
418
Reduced
456
Closed
74

Sector Composition

Rank Sector Weight
1 Technology 26.61%
2 Financials 16.65%
3 Industrials 3.29%
4 Energy 3.1%
5 Consumer Discretionary 2.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FCEL icon
551
FuelCell Energy
FCEL
$1.71B
$846K 0.01%
+2,524
New +$413K
KYNB
552
Kyntra Bio
KYNB
$27.4M
$843K 0.01%
909
-973
-52% -$1.02M
NNDM
553
Nano Dimension
NNDM
$328M
$842K 0.01%
+92,521
New +$469K
SRE icon
554
Sempra
SRE
$57.3B
$838K 0.01%
13,154
-36,826
-74% -$2.37M
BCRX icon
555
BioCryst Pharmaceuticals
BCRX
$2.24B
$837K 0.01%
112,351
-413,951
-79% -$2.13M
EXPE icon
556
Expedia Group
EXPE
$35.8B
$836K 0.01%
6,313
-31,133
-83% -$3.51M
HCA icon
557
HCA Healthcare
HCA
$88B
$834K 0.01%
5,070
-483
-9% -$70.6K
NVAX icon
558
Novavax
NVAX
$1.22B
$832K 0.01%
7,465
-13,323
-64% -$1.42M
FIT
559
DELISTED
Fitbit, Inc. Class A common stock
FIT
$831K 0.01%
122,143
+95,789
+363% +$675K
MRSN
560
DELISTED
Mersana Therapeutics
MRSN
$827K 0.01%
1,243
-1,855
-60% -$1.03M
OPK icon
561
Opko Health
OPK
$978M
$827K 0.01%
209,485
-454,112
-68% -$1.9M
CYTK icon
562
Cytokinetics
CYTK
$10.4B
$825K 0.01%
39,725
-31,392
-44% -$574K
AKBA icon
563
Akebia Therapeutics
AKBA
$351M
$823K 0.01%
294,029
-220,207
-43% -$643K
AMBA icon
564
Ambarella
AMBA
$3.63B
$812K 0.01%
+8,839
New +$619K
KEX icon
565
Kirby Corp
KEX
$6.98B
$812K 0.01%
15,673
+5,584
+55% +$254K
AVB icon
566
AvalonBay Communities
AVB
$27B
$811K 0.01%
5,053
+212
+4% +$33.7K
CTLT
567
DELISTED
CATALENT, INC.
CTLT
$811K 0.01%
7,793
+251
+3% +$24.3K
SRNE
568
DELISTED
Sorrento Therapeutics, Inc.
SRNE
$808K 0.01%
118,452
-195,498
-62% -$1.57M
ARE icon
569
Alexandria Real Estate Equities
ARE
$9.24B
$807K 0.01%
4,530
+189
+4% +$31.2K
ADAP
570
DELISTED
Adaptimmune Therapeutics
ADAP
$803K 0.01%
+149,060
New +$810K
IBRX icon
571
ImmunityBio
IBRX
$7.49B
$801K 0.01%
+60,089
New +$578K
VRNS icon
572
Varonis Systems
VRNS
$4.73B
$796K 0.01%
+14,601
New +$634K
EQR icon
573
Equity Residential
EQR
$25.3B
$792K 0.01%
13,364
-27,059
-67% -$1.53M
MDB icon
574
MongoDB
MDB
$28.8B
$791K 0.01%
+2,203
New +$615K
IMVT icon
575
Immunovant
IMVT
$7.91B
$784K 0.01%
16,968
-4,567
-21% -$211K

Similar funds

Rafferty Asset Management's Q4 2020 Portfolio in Review

As of Q4 2020, Rafferty Asset Management held 1,081 positions worth $10.2B, up 24% from $8.27B the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Rafferty Asset Management deployed $643M of net new capital in Q4 2020, opening 132 new positions and adding to 418 existing holdings. Its largest new stake was Keurig Dr Pepper: 119,771 shares worth $3.83M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 27% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was State Street SPDR S&P Oil & Gas Exploration & Production ETF, an estimated $92.8M trimmed.

  • Rafferty Asset Management's largest Q4 2020 buy was Keurig Dr Pepper: 119,771 shares worth $3.83M.
  • Rafferty Asset Management added most to iShares Russell 2000 ETF in Q4 2020, an estimated $264M increase.
  • Rafferty Asset Management's biggest Q4 2020 reduction was State Street SPDR S&P Oil & Gas Exploration & Production ETF, cutting an estimated $92.8M.
  • Rafferty Asset Management fully exited iShares MSCI EAFE ETF in Q4 2020, selling an estimated $4.41M.
  • Rafferty Asset Management's ten largest holdings make up 43% of its $10.2B portfolio in Q4 2020.
  • Rafferty Asset Management opened 132 new positions and closed 74 in Q4 2020.
  • Rafferty Asset Management's portfolio value rose 24% quarter-over-quarter to $10.2B.

Based on Rafferty Asset Management's 13F filing for Q4 2020, filed 10 Feb 2021.